Tuberculosis

Tuberculosis

ContentsPathophysiologyClinical presentationNON-HIV-Infected patientsHIV-Infected patientsDiagnosisTuberculin skin testSymptomatic diseaseDesired outcomeTreatment of TuberculosisEvaluation of therapeutic outcomes and patient monitoringBuy Most Popular Antibiotic, Antifungal, Antiparasitic, Antiviral Drugs Online no RX & OTC Tuberculosis is a communicable infectious disease caused by Mycobacterium tuberculosis. It can produce silent, latent infection as well as progressive, active disease. Globally, 2 billion people are infected and 2 to 3 million people die from tuberculosis each year. M. tuberculosis is transmitted from person to person by coughing or sneezing. Close contacts of Tuberculosis patients are most likely to become infected. Fifty-one percent of Tuberculosis patients in the United States are foreign born, most often from Mexico, the Philippines, Vietnam, India, China, …

Continue Reading...

Treatment of Tuberculosis

ContentsGeneral principlesPharmacologic treatmentLatent InfectionTreating Active DiseaseDrug ResistanceSpecial PopulationsTuberculous meningitis and Extrapulmonary diseaseChildrenPregnant womenHIV-infected patientsRenal failureBuy Most Popular Antibiotic, Antifungal, Antiparasitic, Antiviral Drugs Online no RX & OTCGeneral principles Drug treatment is the cornerstone of Tuberculosis management. A minimum of two drugs, and generally three or four drugs, must be used simultaneously. Drug treatment is continued for at least 6 months and up to 2 to 3 years for some cases of multidrug-resistant Tuberculosis (MDR-Tuberculosis). Measures to assure adherence, such as directly observed therapy (DOT), are important. Pharmacologic treatment Latent Infection Chemoprophylaxis should be initiated in patients to reduce the risk of progression to active disease. Isoniazid, 300 mg daily in adults, …

Continue Reading...

Management of Tuberculosis

ContentsClinical manifestationsDiagnosis of tuberculosisTreatment of active tuberculosisPrevention of spreadDrug treatment of active tuberculosisVaccination against tuberculosis?Buy Most Popular Antibiotic, Antifungal, Antiparasitic, Antiviral Drugs Online no RX & OTCTuberculosis was a disappearing disease in North America until the early 1980s. However, the spread of human immunodeficiency virus infection has changed that. From 1985 to 1992 there was an increase in the number of cases of tuberculosis reported in the United States, and most of these cases were in New York, New Jersey, Texas, Florida, and California. The other major change in the epidemiology of tuberculosis has been the emergence of multidrug-resistant disease. Factors contributing to this problem in the United States include inadequate …

Continue Reading...

Tuberculosis

ContentsDescription of Medical ConditionMedical Symptoms and Signs of DiseaseWhat Causes Disease?Risk FactorsDiagnosis of DiseaseDifferential DiagnosisLaboratoryPathological FindingsSpecial TestsImagingDiagnostic ProceduresTreatment (Medical Therapy)Appropriate Health CareGeneral MeasuresSurgical MeasuresActivityDietPatient EducationMedications (Drugs, Medicines)Drug(s) of ChoiceAlternative DrugsPatient MonitoringPrevention / AvoidancePossible ComplicationsExpected Course / PrognosisMiscellaneousAssociated ConditionsAge-Related FactorsPregnancySynonymsInternational Classification of DiseasesSee AlsoOther NotesAbbreviationsBuy Most Popular Antibiotic, Antifungal, Antiparasitic, Antiviral Drugs Online no RX & OTCDescription of Medical Condition A common disease transmitted by inhaling airborne bacilli from a person with active tuberculosis (TB). The bacilli multiply in the alveolus and are carried by macrophages, lymphatics and blood to distant sites (eg. lung pleura, brain, kidney and bone). Tissue hypersensitivity usually halts infection within 10 weeks. • Latent tuberculosis infection (LTBI) …

Continue Reading...
CLOSE
CLOSE